Lincoln Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: LINCOLN | BSE: 531633
₹528.70 1.95 (0.37 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 525.95
High (₹) 540.25
Low (₹) 524.45
Prev. Close (₹) 526.75
Volume 13,520
VWAP (₹) 528.99
ROCE (%) 20.34
Industry P/E 43.95
TTM P/E 11.85
P/B Ratio 1.78
Market Cap (₹) Cr.1,055.47
Dividend Yield (%)0.34
EPS (₹) 46.58
ROE15.74%
Sales Growth (%) 13.76
Profit Growth (%)27.99
Day Range
540.25540.25
52 Week Range
498.00975.00
Historical Returns
Returns (6M)
-30.16 %
Returns (1Y)
-8.3 %
Returns (3Y)
70.66 %
Returns (5Y)
363.77 %
Returns (6M)
-30.16 %
Returns (1Y)
-8.3 %
Returns (3Y)
70.66 %
Returns (5Y)
363.77 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (27.97%) TTM EPS Growth
- Company with no debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 27.97% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
Technicals
Technical Rating
RSI 16.02
MFI 4.44
ATR 40.78
Commodity Channel Index -97.91
ROC125 -25.51
ROC21 -25.43
Williams %R -97.91
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 550.46 | 580.53 | 598.01 | 532.98 | 502.91 | 485.43 | 455.36 |
Week Ago | 580.21 | 593.58 | 605.26 | 568.53 | 555.16 | 543.48 | 530.11 |
Month Ago | 695.56 | 715.08 | 741.26 | 669.38 | 649.86 | 623.68 | 604.16 |
EMA & SMA
528.70
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 558.89
9 Day 563.33
10 Day 560.62
12 Day 597.91
14 Day 608.89
20 Day 639.25
26 Day 651.43
50 Day 726.45
100 Day 714.50
200 Day 684.44
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
06 Jun, 2024 | Munjal Mahendrabhai Patel | Acquisition | ₹541.50 | 13,500 | BSE |
03 Jun, 2024 | Munjal Mahendrabhai Patel | Acquisition | ₹568.25 | 20,000 | BSE |
03 Jun, 2024 | Munjal Mahendrabhai Patel | Acquisition | ₹564.60 | 15,000 | BSE |
28 Feb, 2024 | Renukaben Maheshbhai Patel | Disposal | ₹747.29 | 1,500 | BSE |
28 Feb, 2024 | Patel Nishitkumar Maheshbhai | Disposal | ₹751.14 | 1,000 | BSE |
28 Feb, 2024 | Patel Nishitkumar Maheshbhai | Disposal | ₹733.50 | 1,000 | BSE |
24 Feb, 2024 | Renukaben Maheshbhai Patel | Disposal | ₹713.21 | 62,500 | BSE |
24 Feb, 2024 | Patel Nishitkumar Maheshbhai | Disposal | ₹727.23 | 26,500 | BSE |
23 Feb, 2024 | Anand Arvindbhai Patel | Acquisition | ₹690.48 | 30,000 | BSE |
22 Feb, 2024 | Renukaben Maheshbhai Patel | Disposal | ₹710.62 | 11,353 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
16 May, 2024 | Rs.1.8000 per share(18%)Final Dividend | 13 Sept, 2024 | 01 Jan, 1970 |
25 May, 2023 | Rs.1.5000 per share(15%)Dividend | 15 Sept, 2023 | 01 Jan, 1970 |
19 May, 2022 | Rs.1.5000 per share(15%)Dividend | 15 Sept, 2022 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
07 Mar, 2025 | NSE India | The Exchange had sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. |
04 Mar, 2025 | NSE India | The Exchange has sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. |
14 Feb, 2025 | NSE India | Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
13 Feb, 2025 | NSE India | Integrated Filing (Financial) for the Quarter and Nine Months ended 31st December, 2024 |
13 Feb, 2025 | BSE India | Integrated Filing (Financials) for the Quarter and Nine Months ended 31st December, 2024. |
13 Feb, 2025 | BSE India | UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED ON 31.12.2024\r\n |
13 Feb, 2025 | NSE India | Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
13 Feb, 2025 | BSE India | UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2024 |
05 Feb, 2025 | NSE India | LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
05 Feb, 2025 | BSE India | LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December, 2024 And Other Business if any. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 06 Feb, 2025 | 13 Feb, 2025 |
Quarterly Results | -- | 06 Nov, 2024 | 14 Nov, 2024 |
Quarterly Results | -- | 31 Jul, 2024 | 08 Aug, 2024 |
Audited Results & Final Dividend | -- | 10 May, 2024 | 16 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 08 Feb, 2024 |
Quarterly Results | -- | 25 Oct, 2023 | 02 Nov, 2023 |
Quarterly Results | -- | 31 Jul, 2023 | 10 Aug, 2023 |
Audited Results & Dividend | -- | 16 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 01 Feb, 2023 | 09 Feb, 2023 |
Quarterly Results | -- | 31 Oct, 2022 | 10 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Lincoln Pharmaceuticals
Lincoln Pharmaceuticals is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 580.55 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. Mahendra G Patel
NSE Symbol
LINCOLN
Lincoln Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Kishor M Shah | Non Executive Chairman |
Mr. Mahendra G Patel | Managing Director |
Mr. Hashmukh I Patel | Whole Time Director |
Mr. Munjal M Patel | Whole Time Director |
Mr. Ashish R Patel | Whole Time Director |
Mr. Rajnikant G Patel | Non Executive Director |
Mr. Nareshkumar Suthar | Independent Director |
Mr. Saurin J Parikh | Independent Director |
Ms. Seema Mehta | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Lincoln Pharmaceuticals
What is the share price of Lincoln Pharmaceuticals?
The share price of Lincoln Pharmaceuticals on 13 Mar, 2025 is ₹ 528.70.
What is 52W high and 52W low share price of Lincoln Pharmaceuticals?
The highest and lowest 52W share prices of Lincoln Pharmaceuticals are ₹ 975.000 and ₹ 498.000
What is the market cap of Lincoln Pharmaceuticals?
The market capitalization of Lincoln Pharmaceuticals as of 13 Mar, 2025 is ₹ 1,055.47 Crores
What is the P/E ratio of Lincoln Pharmaceuticals?
The current P/E ratio of Lincoln Pharmaceuticals as of 13 Mar, 2025 is 43.95
What is the PB ratio of Lincoln Pharmaceuticals?
The PB ratio of Lincoln Pharmaceuticals as of 13 Mar, 2025 is 1.78
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)